Aprea Therapeutics, Inc. (APRE)
R&D Expense Growth
-24.78%
Fiscal year · Period ending:
APRE R&D Expense Growth
Latest reported-24.78%period ending
Latest reported-24.78%period ending
APRE FY R&D Growth (YoY) (0.00% → -24.78%)
Latest values, visible window
High-resolution chart · PNG
APRE r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -24.7823% | |
| 22.7604% | |
| -91.7471% | |
| 286.7716% | |
| -36.9158% | |
| 80.8024% | |
| 47.5947% | |
| 5.9891% | |
| 0% |